An overview of treatment response rates to various anti-viral drugs in Pakistani Hepatitis B Virus infected patients
Open Access
- 15 January 2011
- journal article
- review article
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 20
Abstract
Hepatitis B virus (HBV) is one of the leading health problem with up to 350 million affected people worldwide including 4.5 million only in Pakistan. It has mortality rate of 0.5 to 1.2 million per year worldwide. Pakistan lies in the endemic region with 3-5% HBV carrier rate in the country. The present article reviews the literature on the treatment response of HBV prevalent in Pakistani population. The average treatment response of Lamivudine and interferon-α is 25.81% and 47.95%, respectively. Peg-Interferon was shown to be not effective against the HBV/HCV (hepatitis C virus)/HDV (hepatitis Delta virus) co-infection. The present study reveals that interferon-α is the most effective therapy available for HBV infection prevalent in Pakistani population. Genotype C & D are the most common HBV genotypes in Pakistan and are associated with increased severity and less response to interferon therapy. This poses a great challenge for physicians and researchers and further studies are needed to describe the outcome of the current therapies recommended against HBV infection in Pakistani population.Keywords
This publication has 43 references indexed in Scilit:
- Pros and Cons of Peginterferon Versus Nucleos(t)ide Analogues for Treatment of Chronic Hepatitis BCurrent Hepatitis Reports, 2010
- Hepatitis B virus genotypes, subgenotypes, precore, and basal core promoter mutations in the two largest provinces of PakistanJournal of Gastroenterology and Hepatology, 2009
- Hepatitis B virus subgenotypes D1 and D3 are prevalent in PakistanBMC Research Notes, 2009
- New Complex Recombinant Genotype of Hepatitis B Virus Identified in VietnamJournal of Virology, 2008
- Current approaches for treating chronic hepatitis B: when to start, what to start with, and when to stopHepatology International, 2008
- Virologic Monitoring of Hepatitis B Virus Therapy in Clinical Trials and Practice: Recommendations for a Standardized ApproachGastroenterology, 2008
- Seroprevalence of Hepatitis B and C Genotypes Among Young Apparently Healthy Females of Karachi-PakistanLibyan Journal of Medicine, 2008
- Common Genotypes of Hepatitis B virus prevalent in Injecting drug abusers (addicts) of North West Frontier Province of PakistanVirology Journal, 2007
- The association of complex liver disorders with HBV genotypes prevalent in PakistanVirology Journal, 2007
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999